Literature DB >> 8336306

Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells.

K Sperber1, H Quraishi, T H Kalb, A Panja, V Stecher, L Mayer.   

Abstract

To study the effect of hydroxychloroquine on cytokine production by monocytes and T cells, cells were pretreated with varying concentrations of hydroxychloroquine and stimulated with lipopolysaccharide (monocytes), phytohemagglutinin or anti-CD-3 monoclonal antibodies (T cells). Interleukin 1 alpha (IL-1-alpha), IL-6 and tumor necrosis factor alpha (TNF-alpha) production were measured from the stimulated monocytes and IL-2, IL-4 and gamma interferon (IFN-gamma) were measured from the stimulated T cells. Hydroxychloroquine inhibited production of IL-1-alpha (monocytes) and IL-6 (T cells and monocytes). In contrast IL-2, IL-4, TNF-alpha and IFN-gamma production were not affected. Preferential inhibition of IL-1-alpha production by monocytes and IL-6 production by T cells and monocytes may contribute to its antiinflammatory effect in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336306

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  44 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

3.  Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.

Authors:  L Zhao; H Ma; Z Jiang; Y Jiang; N Ma
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.

Authors:  Ruitong Gao; Wei Wu; Yubing Wen; Xuemei Li
Journal:  Int Urol Nephrol       Date:  2017-03-27       Impact factor: 2.370

5.  Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.

Authors:  R Willis; A M Seif; G McGwin; L A Martinez-Martinez; E B González; N Dang; E Papalardo; J Liu; L M Vilá; J D Reveille; G S Alarcón; S S Pierangeli
Journal:  Lupus       Date:  2012-02-17       Impact factor: 2.911

6.  Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.

Authors:  K Sperber; L Silverstein; C Brusco; C Yoon; G E Mullin; L Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

7.  Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

Authors:  Andrew L Gilman; Kirk R Schultz; Frederick D Goldman; George E Sale; Mark D Krailo; Zhengjia Chen; Bryan Langholz; David A Jacobsohn; Ka-Wah Chan; Robin E Ryan; Michael Kellick; Steven M Neudorf; Kamar Godder; Eric S Sandler; Indira Sahdev; Stephan A Grupp; Jean E Sanders; Donna A Wall
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-30       Impact factor: 5.742

Review 8.  Anti-inflammatory agents in Alzheimer's disease.

Authors:  Paul S Aisen
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

9.  Impairment of monocytic function during Trypanosoma cruzi infection.

Authors:  M J Louie; W R Cuna; C Rodriguez De Cuna; L Mayer; K Sperber
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

10.  Potentially Beneficial Effect of Hydroxychloroquine in a Patient with a Novel Mutation in Protein Kinase Cδ Deficiency.

Authors:  Ayca Kiykim; Ismail Ogulur; Safa Baris; Elisabeth Salzer; Elif Karakoc-Aydiner; Ahmet Oguzhan Ozen; Wojciech Garncarz; Tatjana Hirschmugl; Ana Krolo; Ayse Deniz Yucelten; Kaan Boztug; Isil B Barlan
Journal:  J Clin Immunol       Date:  2015-08-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.